Impact of alcohol drinking and tobacco smoking on the drug-resistance of newly diagnosed tuberculosis: a retrospective cohort study in Shandong, China, during 2004-2020.

Song, Wan-Mei; Li, Shi-Jin; Liu, Jin-Yue; Fu, Qi; Xu, Ting-Ting; Tao, Ning Ning; Zhang, Qian-Yun; Liu, Si-Qi et al. · BMJ Open · 2022

retrospective_cohort · Level III

Where this comes from

Abstract

To investigate the independent and collective impact of alcohol drinking and tobacco smoking on the drug-resistance of newly diagnosed tuberculosis (TB). This was a retrospective cohort study. Shandong, China. Patients with newly diagnosed TB from 1 January 2004 to 31 December 2020 were collected. Exclusive criteria: retreated cases; extrapulmonary tuberculosis; without information on drug susceptibility testing results, smoking or drinking habits; bacteriological identification as <i>non-tuberculous mycobacteria</i>. Patients were classified into four groups including smokers only (G<sub>1</sub>), drinker only (G<sub>2</sub>), smoker +drinker (G<sub>3</sub>), non-smoker +non-drinker group (G<sub>0</sub>). We described the drug-resistant profiles, clinical factors and calculated the ORs of different drug-resistance among G<sub>1</sub>, G<sub>2</sub>, G<sub>3</sub>, compared with G<sub>0</sub> through univariate and multivariate logistics regression models. Of the 7996 TB cases enrolled, the proportions of G<sub>1</sub>, G<sub>2</sub>, G<sub>3</sub> and G<sub>0</sub> were 8.25%, 3.89%, 16.46% and 71.40%, respectively. The rates of drug-resistant (DR)-TB, mono-resistant TB, multidrug resistant (MDR)-TB, polydrug resistant TB in G<sub>1,</sub> G<sub>2</sub>, G<sub>3</sub> and G<sub>0</sub> were 19.24%/16.4%/17.33%/19.08%, 11.52%/8.68%/10.94%/11.63%, 3.03%/2.57%/2.96%/3.66% and 4.70%/4.82%/3.34%/ 4.08%, respectively. G<sub>3</sub> had a higher risk of MDR1: isoniazid +rifampin (adjusted OR (aOR)=1.91, 95% CI: 1.036 to 3.532), but had a lower risk of DR-TB (aOR=0.84, 95% CI: 0.71 to 0.99), rifampin-related resistance (aOR=0.68, 95% CI: 0.49 to 0.93), streptomycin-related resistance (aOR=0.82, 95% CI: 0.68 to 0.99), ethambutol-related resistance (aOR=0.57, 95% CI: 0.34 to 0.95), MDR3: isoniazid +rifampin+streptomycin (aOR=0.41, 95% CI: 0.19 to 0.85), any isoniazid +streptomycin resistance (aOR=0.85, 95% CI: 0.71 to 1.00). However, there were no significant differences between G<sub>1</sub> and G<sub>0</sub>, G<sub>2</sub> and G<sub>0</sub> in all drug-resistant subtypes. Those patients with cavity had a higher risk of DR-TB among G<sub>3</sub> (OR=1.35, 95% CI: 1.01 to 1.81). Although we did not found an independent impact of alcohol drinking or tobacco smoking on TB drug-resistance, respectively, these two habits had a combined effect on TB drug-resistance.

Medical subject headings